Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Crinetics Pharmaceuticals (CRNX) Shares Issued (2017 - 2025)

Crinetics Pharmaceuticals has reported Shares Issued over the past 9 years, most recently at $2.9 million for Q2 2025.

  • For Q2 2025, Shares Issued rose 42.08% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $2.9 million, down 99.79%, while the annual FY2024 figure was $985.0 million, 166.54% up from the prior year.
  • Shares Issued for Q2 2025 was $2.9 million at Crinetics Pharmaceuticals, down from $952.2 million in the prior quarter.
  • Over five years, Shares Issued peaked at $952.2 million in Q4 2024 and troughed at -$112.5 million in Q4 2022.
  • A 5-year average of $105.9 million and a median of $1.5 million in 2022 define the central range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 275040.48% in 2022 and fell as far as 15367.44% in 2022.
  • Year by year, Shares Issued stood at $737000.0 in 2021, then tumbled by 15367.44% to -$112.5 million in 2022, then soared by 427.44% to $368.4 million in 2023, then skyrocketed by 158.43% to $952.2 million in 2024, then plummeted by 99.7% to $2.9 million in 2025.
  • Business Quant data shows Shares Issued for CRNX at $2.9 million in Q2 2025, $952.2 million in Q4 2024, and $48.3 million in Q3 2024.